Internal Server Error

AI Proteins - About the company

AI Proteins is a series A company based in Boston (United States), founded in 2021. It operates as a Developer of de novo designed miniproteins for therapeutic applications. AI Proteins has raised $59.7M in funding from investors like Sante, Cobro Ventures and Mission BioCapital. The company has 70 active competitors, including 40 funded and 4 that have exited. Its top competitors include companies like Nimbus Therapeutics, Generate Biomedicines and Cradle.

Company Details

Developer of de novo designed miniproteins for therapeutic applications. The company engineers proteins from scratch, controlling function, selectivity, stability, and pharmacology. This allows for the creation of multivalent and multispecific constructs. The designed proteins are intended to minimize off-target effects, drug interactions, and unwanted immune responses. The company aims to deliver biologics that are potent, programmable, and safe.
Social
X
Email ID
*****@aiproteins.com
Key Metrics
Founded Year
2021
Location
Boston, United States
Stage
Series A
Total Funding
$59.7M in 3 rounds
Latest Funding Round
Investors
Ranked
Employee Count
39 as on Aug 31, 2026
Similar Companies
Sign up to download AI Proteins' company profile

AI Proteins's funding and investors

AI Proteins has raised a total funding of $59.7M over 3 rounds. Its first funding round was on Nov 03, 2022. Its latest funding round was a Series A round on Nov 20, 2025 for $*****. 4 investors participated in its latest round. AI Proteins has 5 institutional investors.

Here is the list of recent funding rounds of AI Proteins:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Nov 20, 2025
6803203
Series A
4357829
4783763
8004886
6359776
2023
6586
Grant (prize money)
4082
3223
8065
Nov 03, 2022
2829675
Seed
1079550
7215843
lockAccess funding benchmarks and valuations. Sign up today!

AI Proteins' founders and board of directors

Founder? Claim Profile

AI Proteins' employee count trend

AI Proteins has 39 employees as of Aug 26. Here is AI Proteins's employee count trend over the years:
Employee count trend for AI Proteins
lockUncover AI Proteins' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

AI Proteins's Competitors and alternates

Top competitors of AI Proteins include Nimbus Therapeutics, Generate Biomedicines and Cradle. Here is the list of Top 10 competitors of AI Proteins, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Nimbus Therapeutics
Nimbus Therapeutics
2009, Cambridge (United States), Series F
Developer of targeted therapeutics for cancer, metabolic and inflammatory diseases
$637M
68/100
2nd
Logo for Generate Biomedicines
Generate Biomedicines
2018, Somerville (United States), Public
Developer of a platform for generating novel protein-based therapeutic modalities
$693M
66/100
3rd
Logo for Cradle
Cradle
2021, Zurich (Switzerland), Series B
Provider of chemoproteomics solutions for protein design and development
$103M
64/100
4th
Logo for EvolutionaryScale
EvolutionaryScale
2023, New York City (United States), Seed
Provider of an AI models for protein design
$142M
64/100
5th
Logo for Profluent Bio
Profluent Bio
2022, Berkeley (United States), Series B
Provider of an artificial intelligence-based protein design platform
$150M
64/100
6th
Logo for Frontier Medicines
Frontier Medicines
2018, San Francisco (United States), Series C
Developer of a bioinformatics platform for drug development and chemoproteomics
$236M
62/100
7th
Logo for Eikon
Eikon
2019, Millbrae (United States), Public
Protein tracking and measuring tool for drug discovery
$1.16B
62/100
8th
Logo for Seismic
Seismic
2019, Watertown (United States), Series B
AI-assisted platform for drug discovery and development
$247M
62/100
9th
Logo for Orbit Discovery
Orbit Discovery
2015, Oxford (United Kingdom), Series A
Developer of a drug discovery platforms by peptide display engine
$15.7M
59/100
10th
Logo for Converge
Converge
2024, Wilmington (United States), Series A
Developer of GenAI computational tools for drug discovery and manufacturing
$30.5M
56/100
11th
Logo for AI Proteins
AI Proteins
2021, Boston (United States), Series A
Developer of de novo designed miniproteins for therapeutic applications
$59.7M
56/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on AI Proteins's competitors? Click here to see the top ones

AI Proteins's Investments and acquisitions

AI Proteins has made no investments or acquisitions yet.

Reports related to AI Proteins

Here is the latest report on AI Proteins's sector:

News related to AI Proteins

lockFilter this list
Media has covered AI Proteins for a total of 3 events in the last 1 year.
•
AI Proteins Raises $42M Series A to Launch MiniproteinsEndpoints•Nov 18, 2025•AI Proteins
•
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about AI Proteins

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford